One would hope that the MD would know when the scoping study would be released. In the last price sensitive announcement, David Frances stated it would be finalised within 2 weeks, but the same announcement also had by end of June 2017. There are 3 weeks difference between the MD & the company's timeline.
Wonder who knows what's going on??
One would hope that the MD would know when the scoping study...
Add ERX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.12M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| ERX (ASX) Chart |
Day chart unavailable